Cargando…

Effectiveness and protection duration of Covid-19 vaccines and previous infection against any SARS-CoV-2 infection in young adults

Data on effectiveness and protection duration of Covid-19 vaccines and previous infection against general SARS-CoV-2 infection in general populations are limited. Here we evaluate protection from Covid-19 vaccination (primary series) and previous infection in 21,261 university students undergoing re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rennert, Lior, Ma, Zichen, McMahan, Christopher S., Dean, Delphine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263799/ https://www.ncbi.nlm.nih.gov/pubmed/35803915 http://dx.doi.org/10.1038/s41467-022-31469-z

Ejemplares similares

Covid-19 vaccine effectiveness against general SARS-CoV-2 infection from the omicron variant: A retrospective cohort study
por: Rennert, Lior, et al.
Publicado: (2023)

Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in a University Student Population
por: Rennert, Lior, et al.
Publicado: (2021)

Surveillance-based informative testing for detection and containment of SARS-CoV-2 outbreaks on a public university campus: an observational and modelling study
por: Rennert, Lior, et al.
Publicado: (2021)

Modelling the impact of presemester testing on COVID-19 outbreaks in university campuses
por: Rennert, Lior, et al.
Publicado: (2020)

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
por: Altarawneh, Heba N., et al.
Publicado: (2022)

Duration of immune protection of SARS-CoV-2 natural infection against reinfection
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
por: Hall, Victoria, et al.
Publicado: (2022)

Protection Associated with Previous SARS-CoV-2 Infection in Nicaragua
por: Maier, Hannah E., et al.
Publicado: (2022)

The impact of phased university reopenings on mitigating the spread of COVID-19: a modeling study
por: Rennert, Lior, et al.
Publicado: (2021)

COVID-19 wastewater epidemiology: a model to estimate infected populations
por: McMahan, Christopher S, et al.
Publicado: (2021)

SARS-CoV-2 infection protects against rechallenge in rhesus macaques
por: Chandrashekar, Abishek, et al.
Publicado: (2020)

Analysis of Previous Infection, Vaccinations, and Anti–SARS-CoV-2 Antibody Titers and Protection Against Infection With the SARS-CoV-2 Omicron BA.5 Variant
por: Yamamoto, Shohei, et al.
Publicado: (2023)

Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants
por: Altarawneh, Heba N., et al.
Publicado: (2022)

An epidemiological modeling framework to inform institutional-level response to infectious disease outbreaks: A Covid-19 case study
por: Rennert, Lior, et al.
Publicado: (2023)

ABO phenotype and SARS-CoV-2 infection: Is there any correlation?
por: Mathew, Anna, et al.
Publicado: (2021)

Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections
por: Andeweg, Stijn P., et al.
Publicado: (2022)

SARS-CoV-2 variants of concern Alpha and Delta show increased viral load in saliva
por: King, Kylie L., et al.
Publicado: (2022)

SARS-CoV-2 variants of concern Alpha and Delta show increased viral load in saliva
por: King, Kylie L., et al.
Publicado: (2022)

Vaccine against SARS-CoV-2 in previously infected health care workers
por: Parisi, Saverio Giuseppe
Publicado: (2021)

Is there any effect of flu vaccine on the SARS-CoV-2 infected patients?
por: El-Qutob, D., et al.
Publicado: (2022)

Is there any effect of flu vaccine on the SARS-CoV-2 infected patients?
por: El-Qutob, D., et al.
Publicado: (2022)

Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection
por: Zou, Jing, et al.
Publicado: (2022)

Immunity elicited by natural infection or Ad26.COV2.S vaccination protects hamsters against SARS-CoV-2 variants of concern
por: Tostanoski, Lisa H., et al.
Publicado: (2021)

Children are protected against SARS-CoV-2 infection
por: Dimeglio, Chloé, et al.
Publicado: (2020)

How will previous infection or current vaccination strategies protect us from future SARS‐CoV‐2 variant infections?
por: Monteiro, Olivia
Publicado: (2022)

Protective Duration of ChAdOx1 and BNT162b2 Vaccines Against SARS-CoV-2 Infection
por: Alfaleh, Amjad, et al.
Publicado: (2022)

Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques following SARS-CoV-2 Vaccination and Infection
por: Jacob-Dolan, Catherine, et al.
Publicado: (2021)

Implementation of a Rural Community Diagnostic Testing Strategy for SARS-CoV-2 in Upstate South Carolina
por: Plumb, Emily V., et al.
Publicado: (2022)

Incidence of SARS-CoV-2 infection among previously infected or vaccinated employees
por: Kojima, N., et al.
Publicado: (2022)

The duration of infectiousness of individuals infected with SARS-CoV-2
por: Walsh, Kieran A., et al.
Publicado: (2020)

Correlates of Protection Against SARS-CoV-2 in Rhesus Macaques
por: McMahan, Katherine, et al.
Publicado: (2020)

Protections against the Risk of Airborne SARS-CoV-2 Infection
por: McDonald, Clement J.
Publicado: (2020)

Infectivity of SARS-CoV-2 and protection against reinfection in rats
por: Yu, Dandan, et al.
Publicado: (2022)

Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2
por: Tostanoski, Lisa H., et al.
Publicado: (2021)

Mediterranean Diet and SARS-COV-2 Infection: Is There Any Association? A Proof-of-Concept Study
por: Ponzo, Valentina, et al.
Publicado: (2021)

Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants
por: Ibarrondo, F. Javier, et al.
Publicado: (2021)

Protection afforded by previous Vibrio cholerae infection against subsequent disease and infection: A review
por: Leung, Tiffany, et al.
Publicado: (2021)

Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates
por: Zhu, Daniel Y., et al.
Publicado: (2022)

Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2
por: Tostanoski, Lisa H., et al.
Publicado: (2021)

Rotational thromboelastometry in young, previously healthy patients with SARS-Cov2
por: Lazar, Michael, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m09sdkirpjs5n3ioon1692rpa1